Nexium Buyers End Trial Saying AstraZeneca Paid Off Rivals
As the first pay-for-delay class action trial drew to a close Wednesday, Nexium buyers told the jury that AstraZeneca PLC had stalled generic versions of the heartburn treatment by giving Ranbaxy...To view the full article, register now.
Already a subscriber? Click here to view full article